SCHEMBL26543804

SCHEMBL26543804

c1ccc(-c2nc(-n3c4ccccc4c4ccc5c(oc6c5c5ccccc5c5c7ccccc7c7ccccc7c65)c43)nc3c2oc2ccccc23)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 10/20 0.35
ALDH1A1 P00352 7/20 0.35
TSHR P16473 5/20 0.35
HPGD P15428 2/20 0.35
LMNA P02545 5/20 0.33
KDM4E B2RXH2 3/20 0.33
POLB P06746 3/20 0.33
HSD17B10 Q99714 3/20 0.33
MAPK1 P28482 2/20 0.33
KMT2A Q03164 6/20 0.33
MEN1 O00255 5/20 0.33
NPSR1 Q6W5P4 3/20 0.33
ADORA2A P29274 1/20 0.33
CSF1R P07333 1/20 0.33
PDGFRB P09619 1/20 0.33
KIT P10721 1/20 0.33
FLT3 P36888 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33
USP2 O75604 1/20 0.32
HTT P42858 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19246725 0.89 MAPT (0.39) MAPTALDH1A1TSHRHPGDLMNA
SCHEMBL19046693 0.87 MAPT (0.38) MAPTALDH1A1TSHRHPGDLMNA
SCHEMBL26543237 0.86 KDM4E (0.30) MAPTALDH1A1HPGDKDM4ENPSR1
SCHEMBL19246799 0.85 MAPT (0.38) MAPTALDH1A1TSHRHPGDLMNA
SCHEMBL19986140 0.85 MAPT (0.38) MAPTALDH1A1TSHRHPGDLMNA
SCHEMBL19758270 0.84 MAPT (0.37) MAPTALDH1A1TSHRHPGDLMNA
SCHEMBL20408491 0.84 MAPT (0.39) MAPTALDH1A1TSHRHPGDLMNA
SCHEMBL18165441 0.83 MAPT (0.39) MAPTALDH1A1TSHRHPGDLMNA
SCHEMBL20226383 0.83 TSHR (0.39) MAPTALDH1A1TSHRHPGDLMNA
SCHEMBL16905618 0.83 TSHR (0.44) MAPTALDH1A1TSHRHPGDLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230134350-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME LUMINESCENCE TECHNOLOGY CORP. (TW) 2023-05-04 US disclosed
US-20230134350-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME LUMINESCENCE TECHNOLOGY CORP. (TW) 2023-05-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230134350-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME OR10J3, ODC1, OTC MAPT 1823/4885ALDH1A1 220/4885TSHR 4119/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.